EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Trex Wind Down's enterprise value is $-1.97 Mil.
Trex Wind Down's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-14.32 Mil. Therefore, Trex Wind Down's EV-to-EBITDA for today is 0.14.
The historical rank and industry rank for Trex Wind Down's EV-to-EBITDA or its related term are showing as below:
TMBRQ'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -41.37 Med: 0.22 Max: 0.43
Current: 0.14
During the past 3 years, the highest EV-to-EBITDA of Trex Wind Down was 0.43. The lowest was -41.37. And the median was 0.22.
TMBRQ's EV-to-EBITDA is ranked better than 91.27% of 458
companies
in the Biotechnology industry
Industry Median: 10.31
vs TMBRQ: 0.14
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Trex Wind Down EV-to-EBITDA Historical Data
The historical data trend for Trex Wind Down's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Trex Wind Down's EV-to-EBITDA
For the Biotechnology subindustry, Trex Wind Down's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trex Wind Down's EV-to-EBITDA Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Trex Wind Down's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Trex Wind Down's EV-to-EBITDA falls into.
Trex Wind Down EV-to-EBITDA Calculation
Trex Wind Down's EV-to-EBITDA for today is calculated as:
Trex Wind Down's current Enterprise Value is $-1.97 Mil.
Trex Wind Down's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.32 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trex Wind Down (OTCPK:TMBRQ) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Trex Wind Down's PE Ratio for today is calculated as:
Trex Wind Down's share price for today is $0.0001.
Trex Wind Down's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.380.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Trex Wind Down's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Trex Wind Down (Trex Wind Down) Business Description
Timber Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. Its investigational therapies have mechanisms of action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing, and control) and safety profiles. The company is focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), X-linked recessive CI (XLRI) and autosomal recessive CI (ARCI), and other sclerotic skin diseases. The company's late-stage program is TMB-001., and TMB-003 is the earliest-stage program.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TMBRQ has been successfully added to your 